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While the association of the Gram-positive anaerobic bac-
terium Propionibacterium acnes with the inflammatory skin
condition acne vulgaris has been known for over a century,
its potential role in other human infections and clinical
conditions has undoubtedly been underestimated. This is
likely to reflect inadequate anaerobic processingmethods and
culture of clinical specimens (>7d incubation), combined
with the traditionally held view that P. acnes in a biological
sample simply reflects contamination from the resident skin
microflora or is clinically irrelevant due to a low level of viru-
lence [1]. On such basis, it is likely that an unknown number
of P. acnes infections go undiagnosed and unrecognised. In
addition, subtle clinical signs and symptoms that are often
associated with P. acnes infections may further lead to the
conclusion that an infection is absent, particularly in relation
to prosthetic joints and other indwelling medical devices
[2]. Despite the historical failure to recognise the pathogenic
potential of P. acnes, there is now a growing awareness, as
evidenced in the scientific literature, that the bacterium is
an important cause of opportunistic human infection and
should not be readily dismissed as a contaminant/passive
presence in clinical samples [2–6]. Within the last decade,
advances in our understanding of the population genetic
structure of P. acnes combined with whole genome sequence
(WGS) data now available for a large number of strains,
mostly derived from the Human Microbiome Project, have
provided a platform for hypothesis-driven research into the
exact role of P. acnes in human health and disease and the
possibility of developing vaccines and other novel therapeutic
treatments [7–11]. In particular, the availability ofWGS infor-
mation has enabled both genomic and transcriptomic differ-
ences between lineages from phylogroups associated mainly
with health or disease to be examined, thus identifying
potential genetic determinants and mechanisms of virulence
[11, 12]. Despite its ability to behave as an opportunistic
pathogen, it must not be forgotten that P. acnes is part of
the normal human microbiota and, consequently, also plays
a role in human health via occupation of niches that could
be colonized by other, more pathogenic, microorganisms.
Furthermore, the powerful immunomodulatory properties
of P. acnes have long been investigated for their capacity to
stimulate protective host responses against various human
cancers, and more generally against Th-2-mediated diseases.
In light of the growing interest and recognition of the role of
P. acnes in human health and disease, this special issue aims
to provide a description of recent developments and advances
in different areas of P. acnes research via original research and
review articles, and thus provide a framework to discuss and
identify key issues that need to be addressed in future studies.
Developments in our understanding of P. acnes bacterio-
phages are reviewed in this special issue by H. Bru¨ggemann
and R. Lood. They describe both historical and recent devel-
opments in the field and highlight how genomic analyses
have provided insights into P. acnes phage biology, as well as
the identification of phage sequence signatures in clustered
regularly interspaced short palindromic repeats (CRISPRs)
in P. acnes. They also discuss bacteriophages as a therapeutic
strategy to combat P. acnes-associated diseases, although
there are currently formidable regulatory barriers to this
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approach. In a research paper, G. Kasimatis et al. describe
a comparative genomics study on the acne-derived type
IA
1
strain, HL096PA1, which they found harbours the first
described linear plasmid in P. acnes, pIMPLE-HL096PA1.
Homologues of pIMPLE-HL096PA1 appear to be widely
distributed in ribotype 4 and 5 strains of P. acnes which are
tetracycline resistant and associated with acne [11]. These
plasmids carry a tight adhesion locus (Tad) that may enhance
binding to host cell surfaces. Identification of this novel plas-
mid also provides a potentially new opportunity for genetic
manipulation ofP. acnes and possibly targeted therapy against
specific disease-associated strains. HL096PA1 also contains
fivefoldmore pseudogenes than the type IB strain KPA171202
to which it was compared, as well as island-like regions
unique to the strain; type IB strains have rarely been isolated
from acne lesions. Collectively, this paper provides additional
data on P. acnes virulence properties and host adaptation
mechanisms that may be relevant to our understanding of
acne pathogenesis. Still on the theme of acne, E. A. Eady et al.
in a second review paper hypothesise that the availability of
water and possibly one or more water soluble micronutrients
limits microbial growth within the follicular microenviron-
ment of the skin and that reduction of water activity with
biocompatible solutes of very high solubility may represent
a novel and safe therapeutic approach in acne management.
In an era of growing antibiotic resistance and the continuing
widespread use of oral and topical antibiotics for the first line
treatment of acne, the development of alternative therapeutic
approaches for this extremely common skin condition is
highly desirable.
In this special issue, we also have a research paper by N.
Fischer et al. which describes a study into the intracellular
fate of P. acnes in macrophages. This is an important study
as the ability to persist in macrophages and other cell types
as an intracellular pathogen may be important in the context
of P. acnes-related diseases, particularly acne, sarcoidosis, and
prostate cancer, to which the bacterium has been associated.
This study confirmed the ability of P. acnes to survive
phagocytosis in vitro, although no intracellular replication
or escape from THP-1 host cells were observed. There was
also no evidence of the P. acnes-containing phagosome fusing
with lysosomes. The association of P. acnes with sarcoidosis,
a systemic granulomatous disease, is extensively reviewed
in a paper by Y. Eishi. While sarcoidosis is a disease of
unknown etiology, infectious granulomas are commonly
caused by intracellular pathogens and P. acnes is currently the
only microorganism isolated from sarcoid lesions by culture.
The review proposes mechanisms of granuloma formation
in response to P. acnes in subjects with sarcoidosis and
introduces a new concept of endogenous infection caused
by hypersensitivity to indigenous bacteria. Interestingly, acne
is also a delayed type hypersensitivity reaction, and if the
condition is left untreated granuloma formation can occur
[13]; this is rarely seen today due to clinical intervention. In a
research paper by I. Dekio et al., the intracellular proteomes
of different phylogroups were investigated and variations
in protein expression profiles between strains grown under
different oxygen tensions were examined. A good correlation
was observed between genomic and proteomic profiles for
the major genetic divisions of P. acnes. Differences were also
noted in the intracellular proteome of strains grown under
anaerobic/microaerophilic and aerobic culture conditions,
which could be relevant in the context of P. acnes transfer-
ring from the skin surface to hypoxic/anoxic environments
associated with deep seated systemic infections.
The role of P. acnes as a cause of infections related to
indwelling medical devices is now increasingly recognised,
especially in relation to prosthetic shoulder implants [2, 14].
A study from the Mayo Clinic, described by M. J. Karau
et al., highlights how application of a vortexing-sonication
technique for the detection of bacterial biofilm identifies Pro-
pionibacterium species, likely P. acnes, as common colonizers
of breast tissue expanders. The presence of these colonised
expanders in clinically uninfected subjects may present an
increased risk factor for future infection or capsular con-
tracture. The role of P. acnes in a wide range of implant-
associated infections, along with its clinical management,
is further discussed in a review by M. Portillo et al. They
also describe how sonication of explanted prosthetic material
improves the diagnosis of such infections and suggest that
molecular methods may further increase the sensitivity of
P. acnes detection in the resulting sonicate. In a paper by
J. Rollason et al., P. acnes isolates from surgically excised
lumbar disc herniations are characterised for phylogroup
and antimicrobial susceptibility. Previous studies have sug-
gested a role for P. acnes in the pathophysiology of disc
degeneration and herniation, and antibiotic treatment does
appear to have a positive effect upon patients with chronic
back conditions [15–17]. In this study, type II and III strains
were the predominant phylotypes isolated. Since strains from
these genetic divisions are infrequently recovered from the
skin, this study suggests that the recovery of P. acnes from
excised disc material should not be readily dismissed as
skin contamination in all cases. Furthermore, isolates from
excised discs were susceptible to a range of antimicrobials
commonly used to treat P. acnes-related infections.
In summary, this special issue covers a range of diverse
topics related to P. acnes and disease, thus highlighting
the widespread opportunistic behaviour of the bacterium
in relation to infection. We hope the papers published will
serve to further highlight the pathogenic potential of P.
acnes, as well as stimulating further research into the role
of the bacterium in human health and disease. In particular,
future studies aimed at providing firm evidence of a role in
chronic diseases, such as prostate cancer and disc disease,
may provide exciting new opportunities for novel patient
treatment and management strategies.
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